These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 21310070)

  • 1. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.
    Bo L; Wang F; Zhu J; Li J; Deng X
    Crit Care; 2011; 15(1):R58. PubMed ID: 21310070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
    Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (3):CD003189. PubMed ID: 15266474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Herbst C; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD003189. PubMed ID: 18843642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Br J Haematol; 2003 Aug; 122(3):413-23. PubMed ID: 12877668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte and granulocyte-macrophage colony stimulating factors for newly diagnosed patients with myelodysplastic syndromes.
    Hutzschenreuter F; Monsef I; Kreuzer KA; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009310. PubMed ID: 26880256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factors for chemotherapy-induced febrile neutropenia.
    Mhaskar R; Clark OA; Lyman G; Engel Ayer Botrel T; Morganti Paladini L; Djulbegovic B
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD003039. PubMed ID: 25356786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocyte-monocyte colony-stimulating factor for the treatment of sepsis: a meta analysis].
    Song F; Liu YL; Yang KH; Ma L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):294-8. PubMed ID: 21549068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2004; (1):CD003189. PubMed ID: 14974009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulopoiesis-stimulating factors in the prevention for adverse effects in the therapeutic treatment of malignant lymphoma.
    Bohlius J; Reiser M; Schwarzer G; Engert A
    Cochrane Database Syst Rev; 2002; (4):CD003189. PubMed ID: 12519588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients. A systematic review of the literature with meta-analysis.
    Berghmans T; Paesmans M; Lafitte JJ; Mascaux C; Meert AP; Jacquy C; Burniat A; Steels E; Vallot F; Sculier JP
    Support Care Cancer; 2002 Apr; 10(3):181-8. PubMed ID: 11904782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.
    Ahmad A; Laborada G; Bussel J; Nesin M
    Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants.
    Giles FJ
    Clin Infect Dis; 1998 Jun; 26(6):1282-9. PubMed ID: 9636847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sargramostim (GM-CSF) for induction of remission in Crohn's disease.
    Roth L; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008538. PubMed ID: 22071853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis.
    Xi AR; Luo YJ; Guan JT; Wang WJ; Xu ZH
    Inflammopharmacology; 2023 Feb; 31(1):275-285. PubMed ID: 36445552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.